Effect of Propofol and Sevoflurane on Lactate During Anesthesia for Pediatric Heart Catheterisation (PRISCATHLAB)
|ClinicalTrials.gov Identifier: NCT01293266|
Recruitment Status : Completed
First Posted : February 10, 2011
Last Update Posted : March 11, 2011
|Condition or disease||Intervention/treatment|
|Metabolic Acidosis||Drug: Propofol|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||40 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Effect of Propofol and Sevoflurane on Base Excess, pH and Lactate in Pediatric Heart Catheterisation|
|Study Start Date :||June 2009|
|Primary Completion Date :||August 2010|
|Study Completion Date :||August 2010|
Active Comparator: Propofol
Anesthesia is changed from Sevoflurane to Propofol after obtaining baseline blood gas analysis from the heart catheterisation sheath.
Anesthesia is switched from sevoflurane to propofol after obtaining a baseline blood gas analysis.
Other Name: Disoprivan
No Intervention: Sevoflurane
Sevoflurane anesthesia is maintained after obtaining a baseline blood gas analysis.
- Serum Lactate [ Time Frame: 4 hours ]Serum lactate is measured during application of propofol and sevoflurane to examine the effect on metabolic acidosis.
- pH and base excess [ Time Frame: Hours ]pH and base excess are measured during application of Propofol and Sevoflurane to examine the effect on acid-base balance
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01293266
|University Hospital Schleswig-Holstein, Campus Kiel|
|Kiel, Schleswig-Holstein, Germany, 24105|
|Study Director:||Berthold Bein, Prof. Dr.||University Hospital Schleswig-Holstein, Campus Kiel|